DxH 690T Hematology Analyzer
Streamline workflow and maximize staff walkaway time with the DxH 690T hematology analyzer. This 5-part differential CBC analyzer helps you give your patients rapid results, while enabling your technologists to simplify processes and reduce manual tasks. The benchtop system includes the same automated capabilities and industry-leading 93% first-pass yield of our full-featured DxH 900 hematology analyzer,1 as well as support for the Monocyte Distribution Width (MDW) hematology biomarker. Available exclusively for mid-volume laboratories on the DxH 690T, the MDW helps clinicians identify sepsis in the emergency department (ED) to support faster, targeted treatment.
Deliver Fast, Reliable 5-part Differential Results
Obtain accurate RBC, PLT and WBC test results for clinicians and patients on the first pass through high-resolution analysis of cells in their near-native states. This capability is made possible by the DxH 690T analyzer's reliable core hematology technologies, including the Enhanced Coulter Principle, VCS 360 and DataFusion.Experience 93% first-pass yield to streamline results delivery and enhance throughput
- Receive 1/3 fewer low-confidence flags compared to other mid-volume analyzers1
- Avoid time-consuming manual interventions with more reportable results on the first run
- Support lower operating costs by reducing costly sample reruns and reagent consumption
- Employ real-time analysis to help identify and correct interferences for accurate first-pass runs
- Analyze cytopenic samples using a single aspiration with automated extended counts
- Help produce a reportable WBC differential for samples with lyse-resistant RBC with automatic particle recognition
- Expand diagnostic scope with extended reticulocyte panel, automated body-fluid analysis and exclusive MDW capability
Free Up Staff Time
Improve operational performance by maximizing staff time and instrument uptime. The DxH 690T hematology analyzer is not only designed for reliable performance; it also simplifies—and even eliminates—some operational tasks. This allows the instrument to deliver more work in the day and enables staff members to focus on other priorities.Maximize walkaway time
- Automate QC processes to complete tasks with 75% fewer steps, and 40% faster software response time, than previous generation mid-volume hematology analyzers
- Apply system calibration and QC reminders
- Automate failed QC reruns
- Add direct-from-instrument QC uploads to peer group comparisons (Interlaboratory Quality Assurance Program) and receive near-instant results via email
- Access new guided QC assistance
- Experience fewer manual touch points, zero hands-on daily maintenance and high throughput capability for greater flexibility in staff time allocation
- Eliminate manual daily cleaner loading and unloading with pre-loaded cleaner and remove required power-downs with an autonomous cleaning cycle
- Extend walkaway time with a high sample loading capacity of up to 100 tubes
- Simplify operation with an intuitive, user-friendly interface
- Facilitate training and communication between staff members by displaying instrument task videos and a notepad for messages on the integrated touchscreen monitor
- Upload SOPs, enabling convenient access to laboratory procedures through the system and freeing counter space for manual tasks, such as dilutions and slide making
- Apply extensive sample-specific rule-writing capabilities to automate analysis and standardize SOP sample handling—without the need for middleware
- Resolve events in need of attention with guided prompts and actions from a new software wizard
Casebook Digital Hematology: Advanced Technology Guide
With its advanced theory of operation and near-native cellular characterization, DxH 900 & 690T hematology analyzer technology allows for effective cellular analysis to accurately analyze blood cells and provide clinically significant data to aid in disease identification. Download the casebook to learn more.
Download casebookNews DxH 690T Wins Innovation Award
Frost & Sullivan recognized Beckman Coulter Diagnostics with the 2020 Global New Product Innovation Award for the DxH 690T. The award recognizes the value-added features and benefits of the product and the increased return on investment (ROI) it gives customers, which, in turn, raises customer acquisition and overall market penetration potential.
Learn moreMonocyte Distribution Width
Learn about the regulatory cleared hematology biomarker, automatically available as part of a routine CBC with differential test2, used in the identification of patients with sepsis or at risk for developing sepsis in the emergency department.
Learn more
Sample Aspiration |
|
Methodology |
|
Available Test Menu |
|
Select Tips & Tools to access helpful documents and information for your instrument.
Step 1: To access content such as job aids, checklists, In-Lab Training Manuals, etc., select the Tips & Tools link in the top left navigation.
Step 2: Select the product name.
Step 3: You will be directed to the product page and access to the product-specific content.
Click here to access Tips & Tools
2Using Early Sepsis Indicator application on Beckman Coulter DxH 900 and DxH 690T analyzers. Activation is required..
REMISOL Advance is a trademark or registered trademark of Normand-Info SAS in the United States and other countries. Used under license.